Page 539 - TNFlipTest

Toronto Notes 2019 References Gynecology GY53 References
Agency for Healthcare Research and Quality, Rockville, MD. Available from: http://www.ahrq.gov/clinic/utersumm.htm.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed). Washington DC: American Psychiatric Association; 2013.
Anderson GL, Limacher M, Assaf AR, et al. (WHI Steering Committee). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy – Women’s Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712. ARHP Quick Reference Guide for Clinicians. Managing premenstrual symptoms. June 2008.
Bélisle S, Blake J, Basson R, et al. Canadian consensus conference on menopause, 2006 update. JOGC 2006;28(2 Suppl 1):S1-S94.
Bentley J, Bertrand M, Brydon L, et al. SOGC Joint Clinical Practice Guidelines. Colposcopic management of abnormal cervical cytology and histology, 2012. JOGC 2012;284;1188-1202.
Berek JS, Hacker NF. Gynecologic oncology, 5th ed. Lippincott Williams & Wilkins, 2010.
Brännström M, Johannesson L, et al. Livebirth after uterus transplantation. Lancet 2015;385:607-16.
Burger RA, Brady MF, Bookman MA, et al. Incorporation of bevacizumab in the primary treatment of ovarian cancer. NEJM 2011;365:2473-2483.
Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized control trial. JAMA 2011;305:2295-2303.
Canadian Consensus Conference on Menopause, 2006 Update. JOGC 2006;171.
Centres for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males – Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011;60:1705-1708. Cunningham FG, McDonald PC, Gant NF. Williams obstetrics, 14th ed. Appleton and Lange, 1993.
Davey E, Barratt A, Irwig L, et al. Effect of study design and quality of unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet 2006;367:122-132.
Davis V, Dunn S. Emergency postcoital contraception. SOGC Clinical Practice Guidelines July 2000;82.
Dickey RP. Managing contraceptive pill patients, 9th ed. Fort Collins, CO: EMIS, Inc. Medical Publishers; 1998.
Donnez J, Tomaszewski J, Vasquez F, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids NEJM 2012;366(5):421-432.
Duffy JM, Arambage K, Correa FJ, et al. Laparoscopic surgery for endometriosis. Cochrane DB Syst Rev 2014;4:CD011031.
Elson CJ, Salim R, Potdar N, Chetty M, Ross JA, Kirk EJ on behalf of the Royal College of Obstetricians and Gynaecologists. Diagnosis and management of ectopic pregnancy. BJOG 2016;.123:e15–e55.
Erdman JN. Human rights in health equity: Cervical cancer and HPV vaccines. Am J Law & Medicine 2009;35:365-387.
Espeland MA, Rapp SR, Shumaker SA,f et al. Conjugated equine estrogens and global cognitive function in postmenopausal women – Women’s Health Initiative memory study. JAMA 2004;291:2959-2968.
Guilbert E, Boroditsky R, Black A, et al. Canadian consensus guideline on continuous and extended hormonal contraception. J Obstet Gyn Canada 2007;29:S1-S32.
Hacker NF, Moore JG. Essentials of obstetrics and gynecology, 2nd ed. WB Saunders, 1992.
Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-613.
Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. BJOG 1990;97:922-929.
Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ 2011;342:d2151.
Joura EA, Giuliano AR, Iversen OE et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. NEJM 2015;372:711-723.
Klipping C, Duijkers I, Trummer D, et al. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception 2008;78:16-25.
Lidegaard O, Lokkegaard E, Jensen A, et al. Thrombotic stroke and myocardial infarction with hormonal contraception. NEJM 2012;366:2257-2266.
Lipscomb GH, McCord ML, Stovall TG, et al. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. NEJM 2001;341:1974-1978.
Lopez LM, Chen M, Mullins S, et al. Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane DB Syst Rev 2012;8:CD009849.
Luciano AA, Solima RG. Ectopic pregnancy: from surgical emergency to medical management. Ann NY Acad Sci 2001;943:235-254.
Lujan ME, Chizen DR, Pierson RA. Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. JOGC 2008;30:671-9.
Maclennan AH, Broadbent JL, Lester S, et al. Oral oestrogen and combined oestrogen/progetogen therapy versus placebo for hot flushes. Cochrane DB Syst Rev 2004;18.
Management of uterine fibroids. Summary, Evidence Report/Technology Assessment: Number 34. AHRQ Publication No. 01-E051, January 2001.
Manson JE, Martin KA. Postmenopausal hormone replacement therapy. NEJM 2001;345:34-40.
Mantha S, Karp R, Raghavan V, et al. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 2012; 345:e4944.
Marchbanks PA, Aneger JF, Coulman CB, et al. Risk factors for ectopic pregnancy: a population based study. JAMA 1998;259:1823-1827.
Martin JL, Williams KS, Abrams KR, et al. Systematic review and evaluation of methods of assessing urinary incontinence. Health Technol Assess 2006;10:1-132,iii-iv.
Marjoribanks J, Farquhar C, Roberts H et al. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2017; 1:CD004143.
National guideline for the treatment of bacterial vaginosis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect 1999;75:S1 6-8.
Ontario Cervical Screening Practice Guidelines. June 2005. Available from: http://www.cancercare.on.ca/index – cervical screening.htm.
Ouellet-Hellstram R, Graham DJ, Staffa JA, et al. Combined hormonal contraceptives (CHCs) and the risk of cardiovascular disease endpoints. CHC-CVD final report 111022v2.
Paley PJ. Screening for the major malignancies affecting women: current guidelines. Am J Obstet Gynecol 2001;184:1021-1030.
Public Health Agency of Canada, 2010. Canadian guidelines on sexually transmitted infections. (Updated January 2010). Available from: http://www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/index-eng.php.
Public Health Agency of Canada, 2011. Public health information update on the treatment of gonococcal infection. Available from: http://www.phac-aspc.gc.ca/std-mts/sti-its/alert/2011/alert-gono-eng.php.
PHAC National Advisory Committee on Immunization (NACI). Update on human papillomavirus (HPV) vaccines. Canada Communicable Disease Report 2012;38:ACS-1.
Rambout L, Hopkins L, Hutton B, et al. Prophylactic vaccination against human papillomavirus infection in women: a systematic review of randomized controlled trials. CMAJ 2007;177(5):469-479.
Ratner S, Ofri D. Menopause and hormone replacement therapy. West J Med 2001;175:32-34.
Reade CJ, McVey RM, Tone AA et al. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. J Obstet Gynaceol Can 2014;36:133-140.
Reid R. Oral contraceptives and the risk of venous thromboembolism: an update. SOGC Clinical Practice Guideline. JOGC 2010;32:1192-1197.
Rimsza ME. Counselling the adolescent about contraception. Pediatr Rev 2003;24:162-170.
Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risks of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477.
Seeger JD, Loughlin J, Eng PM, et al. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. Obstet Gynecol 2007;110:587-593.
Setiawan VW, Yang HP, Pike MC, et al. Type I and II Endometrial Cancers: Have They Different Risk Factors? Journal of Clinical Oncology. 2013;31(20):2607-2618. doi:10.1200/JCO.2012.48.2596.
Sexuality and U. Society of Obstetricians and Gynaecologists of Canada. Available from: http://www.sexualityandu.ca.
Shapter AP. Gestational trophoblastic disease. Obs Gynecol Clin North Am 2001;28:805-817.
Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women – Women’s Health Initiative memory study. JAMA 2004; 291:2947-2958. SOGC Clinical Practice Guidelines: Abnormal Uterine Bleeding in Pre-Menopausal Women. JOGC May 2013;35(5 eSupple):S1-S28.
SOGC Clinical Practice Guidelines: Emergency Contraception. JOGC Sep 2012;34(9):870-878. Available from: http://www.sogc.org/guidelines/documents/gui280CPG1209E_000.pdf
SOGC Committee Opinion on Missed Hormonal Contraceptives: New recommendations. JOGC 2008;30:1050-1062. Available from: http://www.sogc.org/guidelines/documents/gui219ECO0811.pdf.
SOGC News Release. New recommendations from national ob/gyn society address Depo-Provera, bone loss. May 2006. Available from: http://www.sogc.org/media/pdf/advisories/dmpa-may2006_e.pdf.
Tang T, Lord JM, Norman RJ et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2012; (5):CD003053.
Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk of malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol 1999;93:448-452.
Wooltorton E. The Evra (ethanyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns. CMAJ 2006;174:164-165.
Wooltorton E. Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss. JAMA 2005;172:746.
Yudin M, Money H, Deborah M, et al. Screening and Management of Bacterial Vaginosis in Pregnancy. Obstet Gynecol Can 2017;39;184-191.